Search Results - "Hao, Mingjing"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    A novel tubulin inhibitor, 6h, suppresses tumor-associated angiogenesis and shows potent antitumor activity against non–small cell lung cancers by Liu, Zi, Huang, Liancheng, Zhou, Tianhao, Chang, Xing, Yang, Yuying, Shi, Yani, Hao, Mingjing, Li, Zengqiang, Wu, Yingliang, Guan, Qi, Zhang, Weige, Zuo, Daiying

    Published in The Journal of biological chemistry (01-07-2022)
    “…Tumor angiogenesis is closely associated with the metastasis and progression of non–small cell lung cancer (NSCLC), a highly vascularized solid tumor. However,…”
    Get full text
    Journal Article
  2. 2

    Mechanism of Self-Assembled Celastrol-Erianin Nanomedicine for treatment of breast cancer by Tian, Jiahang, Chen, Kun, Zhang, Qian, Qiu, Chong, Tong, Haibo, Huang, Jingnan, Hao, Mingjing, Chen, Junhui, Zhao, Wentong, Wong, Yin-Kwan, Gao, Lei, Luo, Piao, Wang, Jigang, Du, Qingfeng

    “…•Nanoparticles for breast cancer treatment, termed CEN, were prepared by self-assembling the natural compounds celastrol and erianin.•Using the ABPP method,…”
    Get full text
    Journal Article
  3. 3

    The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose by Gao, Minghuan, Yang, Yuying, Gao, Ying, Liu, Tong, Guan, Qi, Zhou, Tianhao, Shi, Yani, Hao, Mingjing, Li, Zengqiang, Zuo, Daiying, Zhang, Weige, Wu, Yingliang

    Published in Chemico-biological interactions (25-02-2022)
    “…Aerobic glycolysis is a hallmark of malignant tumor. Here, the hyperactive glycolysis in multidrug-resistant A549/Taxol cells was demonstrated to be essential…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Chemoproteomics Reveals Glaucocalyxin A Induces Mitochondria‐Dependent Apoptosis of Leukemia Cells via Covalently Binding to VDAC1 by An, Yehai, Zhang, Qian, Chen, Yu, Xia, Fei, Wong, Yin‐Kwan, He, Hengkai, Hao, Mingjing, Tian, Jiahang, Zhang, Xiaoyong, Luo, Piao, Wang, Jigang

    Published in Advanced biology (01-02-2024)
    “…Chronic myelogenous leukemia (CML) that is resistant to tyrosine kinase inhibitors is one of the deadliest hematologic malignancies, and the T315I mutation in…”
    Get full text
    Journal Article